TGFB1 and Hepatic fibrosis: In conclusion, our results showed that suppression of TGF-β/smad signaling pathway, in addition to downregulation of the down-stream fibrotic genes of TGF-β1/smad signaling pathway but also via modulation of effective microRNA expressions on the pathogenesis of liver fibrosis, may have desirable therapeutic effects.